Adherence to complex combination antiretroviral therapies by HIV- positive drug abusers

Psychiatric Services

Volumn 49, Issue 8, 1998, Pages 1021-1022

  Malow, Robert M ^a,b   McPherson, Shvahn ^a   Klimas, Nancy ^a   Antoni, Mike H ^a   Schneiderman, Neil ^a   Penedo, Frank J ^a   Ziskind, David ^a   Page, Bryan ^a   McMahon, Robert ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

COMBINATION CHEMOTHERAPY; DRUG ABUSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; SHORT SURVEY;

EID: 0031928017     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.8.1021     Document Type: Short Survey

References (14)

1. Bangsberg D, Tulsky JP, Hecht FM, et al: Protease inhibitors in the homeless. JAMA 278:63-65, 1997
2. Schneiderman N, Antoni MH, Ironson G: Cognitive-behavioral stress management and secondary prevention in HIV/AIDS. Psychology and AIDS Exchange 22:1-8, 1997
3. Besche C, Collins G, Morse E, et al: Characteristics associated with participant compliance in two CPCRA trials. Proceedings of the Eighth International Conference on AIDS, abstract PU-B7040. Stockholm, International AIDS Society, 1992
4. Cortese L, Chung R, Stoute J, et al: Zidovudine usage: patient compliance and factors. Proceedings of the Ninth International Conference on AIDS, abstract PO-332-2233. Stockholm, International AIDS Society, 1993
5. LoCaputo S, Maggi P, Buccoliero G, et al: Antiretroviral therapy with zidovudine: evaluation of the compliance in a cohort of HIV-positive patients. Proceedings of the Ninth International Conference on AIDS, abstract PO-B26-2124. Stockholm, International AIDS Society, 1993
6. Muma R, Ross W, Parcel G, et al: Zidovudine adherence among individuals with HIV infection. AIDS Care 7:439-448, 1995
7. Singh N, Squier C, Sivek C, et al: Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 8:261-269, 1996
8. Blumenfield M, Milazzo J, Wormser G: Non-compliance in hospitalized patients with AIDS. General Hospital Psychiatry 12:166-169, 1990
9. Freeman RC, Rodriquez G, French JF, Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue. AIDS Education and Prevention 8:58-71, 1996
10. Wall TL, Sorensen JL, Batki SL, et al: Adherence to zidovudine (AZT) among HIV infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence 37:261-269, 1995
11. Ferrando SJ, Wall TL, Batki SL, et al: Psychiatric morbidity, illicit drug use, and adherence to zidovudine (AZT) among injection drug users with HIV disease. American Journal of Drug and Alcohol Abuse 4:475-487, 1996
12. Morse E, Simon P, Coburn M, et al: Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine 32:1161-1167, 1991
13. Smith PC, Page JB: Medication therapy among intravenous drug users (IDUs) with HIV infection. AIDS Patient Care 2:101-110, 1996
14. Cohen V: Assessment of Adherence to Antiretroviral Therapy. Doctoral dissertation. Miami, University of Miami, Department of Pharmacology, 1997